Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Gene Body Methylation Directly Increases Gene Expression and is a Therapeutic Target for Genes Upregulated in Cancer (gene expression)

ABSTRACT: Demethylation treatment reduce gene body methylation as well as gene expression

ORGANISM(S): Homo sapiens

PROVIDER: GSE51811 | GEO | 2014/08/01

SECONDARY ACCESSION(S): PRJNA225478

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Similar Datasets

Gene Body Methylation Directly Increases Gene Expression and is a Therapeutic Target for Genes Upregulated in Cancer (methylation)

Project description:Demethylation treatment reduce gene body methylation as well as gene expression Bisulphite converted DNA from the 22 samples were hybridised to the Illumina Infinium HM450 Human Methylation Beadchip

2014-08-01 | E-GEOD-51810 | biostudies-arrayexpress

Gene Body Methylation Directly Increases Gene Expression and is a Therapeutic Target for Genes Upregulated in Cancer (gene expression)

Project description:Demethylation treatment reduce gene body methylation as well as gene expression Total RNA obtained from untreated and treated cell lines were hybridised to the HumanHT12_V4 Human Expression Beadchip

2014-08-01 | E-GEOD-51811 | biostudies-arrayexpress

Gene Body Methylation Directly Increases Gene Expression and is a Therapeutic Target for Genes Upregulated in Cancer (methylation)

Project description:Demethylation treatment reduce gene body methylation as well as gene expression

2014-08-01 | GSE51810 | GEO

Gene Body Methylation Directly Increases Gene Expression and is a Therapeutic Target for Genes Upregulated in Cancer

Project description:This SuperSeries is composed of the SubSeries listed below. Refer to individual Series

2014-08-01 | E-GEOD-51815 | biostudies-arrayexpress

Gene Body Methylation Directly Increases Gene Expression and is a Therapeutic Target for Genes Upregulated in Cancer

Project description:This SuperSeries is composed of the SubSeries listed below.

2014-08-01 | GSE51815 | GEO

Gene body methylation can alter gene expression and is a therapeutic target in cancer.

Project description: Not available

| S-EPMC4224113 | biostudies-literature

ROR1 is upregulated in endometrial cancer and represents a novel therapeutic target.

Project description: Not available

| S-EPMC7431863 | biostudies-literature

Acid ceramidase is upregulated in AML and represents a novel therapeutic target.

Project description: Not available

| S-EPMC5347763 | biostudies-literature

The Notch target Hes1 directly modulates Gli1 expression and Hedgehog signaling: a potential mechanism of therapeutic resistance.

Project description: Not available

| S-EPMC3059501 | biostudies-literature

Paclitaxel resistance in ovarian cancer increases oncolytic adenovirus efficacy via upregulated CAR expression and dysfunctional cell cycle control

Project description:The microtubule-stabilising drug paclitaxel has activity in relapsed ovarian cancer. However, resistance frequently develops. Oncolytic adenoviruses are a novel cancer therapy, and replicate selectively within and lyse malignant cells, leading to productive infection of neighbouring cells. We found increased efficacy of adenoviruses of multiple subtypes in paclitaxel-resistant ovarian cancer cells. There was increased expression of a key adenovirus receptor, CAR (coxsackie adenovirus receptor), due to increased transcription that resulted from histone modification. Moreover, CAR transcription increased in intraperitoneal xenografts with acquired paclitaxel resistance and in tumours from patients with paclitaxel-resistant ovarian cancer. Finally, we identified dysregulated cell cycle control as a second mechanism of increased adenovirus efficacy in paclitaxel-resistant ovarian cancer and that inhibition of CDK4/6 using PD-0332991 was able both to reverse paclitaxel resistance and reduce adenovirus efficacy. Thus, paclitaxel resistance increases oncolytic adenovirus efficacy via at least two separate mechanisms. Parental SKOV3 and paclitaxel-resistant SKOV3-TR cells were analysed in duplicate

2015-12-10 | E-GEOD-54772 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data